登录 注册 会员服务 联系我们

Cell proliferation and outcome following doxorubicin plus CMF regimens in node‐positive breast cancer

  • Published:2000-07-10 Issue:3 Volume:87 Page:405-411
  • ISSN:0020-7136
  • Container-title:International Journal of Cancer
  • language:en
  • Short-container-title:Int. J. Cancer

Author:

Silvestrini Rosella1,Luisi Antonella1,Zambetti Milvia2,Cipriani Sonia2,Valagussa Pinuccia3,Bonadonna Gianni3,Daidone Maria Grazia1

Affiliation:

1. Department of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy

2. Department of Medical Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy

3. Scientific Direction, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference26 articles.

1. Prospective use of tumor proliferative activity for adjuvant therapy in node‐negative breast cancer patients;Amadori D.;Cell Prolif.,1997

2. Sequential or alternating doxorubicin and CMF regimens in breast cancer with more than three positive nodes;Bonadonna G.;J. amer. med. Assoc.,1995

3. Changes in biological markers after primary chemotherapy for breast cancers

4. Flexible regression models with cubic splines
同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3